October 8, 2024
NCI at Frederick Conference Center
Building 549
549 Sultan Drive
Fort Detrick
Frederick, MD 21702
Conference Center Auditorium


This annual event honors the outstanding research accomplishments of David Derse, Ph.D., a Principal Investigator in the Center for Cancer Research's HIV Dynamics and Replication Program (HIV DRP).

Dr. Derse was Head of the Retrovirus Gene Expression Section in the HIV DRP. During his 25 years at the National Cancer Institute, he investigated the molecular mechanisms of retrovirus infection and replication, concentrating most recently on the human viruses HIV-1 and HTLV-1. In 2007, Dr. Derse and his research team discovered how HTLV-1 evades the body's natural defenses to fight off infection, a finding that may eventually lead to improved antiviral therapies and new strategies for preventing some types of cancer.

The HIV DRP sponsors the Annual David Derse Memorial Lecture and Award, with support from Hye Kyung Chung-Derse and the National Cancer Institute, to foster the scientific discourse and exchange of innovative ideas that Dr. Derse was well known for promoting throughout his scientific career.

Carol A. Carter, Ph.D., SUNY Distinguished Professor of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University will deliver the 13th lecture in this series on October 8, 2024. The title of her presentation is "HOST-TARGETED THERAPEUTICS: Prazoles Target Tsg101 Ubiquitin E2 Variant Mimicry".

In addition to the zoom broadcast of the lecture and award presentation, an archived videocast will be available on the NIH VIDEOCAST WEBSITE.

We hope you will join us on October 8, 2024.


Register Now!